MAPT and Mental deterioration: Most importantly, amyloid-β biomarkers discordance represents a strong predictor of future progression toward full amyloid-β biomarkers abnormalities (Fig. 2), thus allowing prompt identification of individuals that will be at higher subsequent risk for clinical progression and cognitive decline, steeper rates of neurodegeneration, and tau pathology [14, 15, 19, 28].